Correlation Between Aileron Therapeutics and Gemina Laboratories
Can any of the company-specific risk be diversified away by investing in both Aileron Therapeutics and Gemina Laboratories at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aileron Therapeutics and Gemina Laboratories into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aileron Therapeutics and Gemina Laboratories, you can compare the effects of market volatilities on Aileron Therapeutics and Gemina Laboratories and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aileron Therapeutics with a short position of Gemina Laboratories. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aileron Therapeutics and Gemina Laboratories.
Diversification Opportunities for Aileron Therapeutics and Gemina Laboratories
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aileron and Gemina is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Aileron Therapeutics and Gemina Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gemina Laboratories and Aileron Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aileron Therapeutics are associated (or correlated) with Gemina Laboratories. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gemina Laboratories has no effect on the direction of Aileron Therapeutics i.e., Aileron Therapeutics and Gemina Laboratories go up and down completely randomly.
Pair Corralation between Aileron Therapeutics and Gemina Laboratories
Given the investment horizon of 90 days Aileron Therapeutics is expected to under-perform the Gemina Laboratories. But the stock apears to be less risky and, when comparing its historical volatility, Aileron Therapeutics is 1.69 times less risky than Gemina Laboratories. The stock trades about -0.52 of its potential returns per unit of risk. The Gemina Laboratories is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 40.00 in Gemina Laboratories on September 13, 2024 and sell it today you would earn a total of 15.00 from holding Gemina Laboratories or generate 37.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aileron Therapeutics vs. Gemina Laboratories
Performance |
| Timeline |
| Aileron Therapeutics |
| Gemina Laboratories |
Aileron Therapeutics and Gemina Laboratories Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aileron Therapeutics and Gemina Laboratories
The main advantage of trading using opposite Aileron Therapeutics and Gemina Laboratories positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aileron Therapeutics position performs unexpectedly, Gemina Laboratories can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gemina Laboratories will offset losses from the drop in Gemina Laboratories' long position.| Aileron Therapeutics vs. Bio Path Holdings | Aileron Therapeutics vs. Benitec Biopharma Ltd | Aileron Therapeutics vs. Artelo Biosciences | Aileron Therapeutics vs. Histogen |
| Gemina Laboratories vs. Novo Nordisk AS | Gemina Laboratories vs. Genmab AS | Gemina Laboratories vs. Inhibikase Therapeutics | Gemina Laboratories vs. Purple Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |